Effect of smoking on treatment outcomes among newly diagnosed Tuberculosis patients in Shimla.
DOI:
https://doi.org/10.47203/IJCH.2019.v31i02.007Keywords:
Tuberculosis outcome; Smoking; Cohort study; AlcoholAbstract
Introduction: World Health Organization in 2015 had adopted “End TB Strategy” aimed at ending the global TB epidemic by 2035. Tobacco smoking has been reported to be associated with many aspects of TB disease, including increased vulnerability to being infected, recurrence with TB and related mortality. Aims & Objectives: To determine effect of smoking on treatment outcomes of tuberculosis patients at the end of six months of standardized tuberculosis treatment. Material & Methods: A prospective cohort study was carried out among newly diagnosed tuberculosis patients of Shimla city of India. Data related to smoking status was collected using the standard questionnaire which was used for collection of data regarding tobacco use in Global Adult Tobacco Survey (GATS). Details of the participant’s final treatment outcomes after end of standardized treatment of 6 months was collected from the treatment records of the patients available in the office of district TB center. Results: 72 TB patients were included as study subjects. The prevalence of smoking came out to be 37.5% (95% CI: 26.4-49.7). In our analyses, the risk of unfavorable treatment outcomes was higher among smokers (p value 0.049), Smokeless tobacco users (p value 0.031) and those with history of harmful alcohol use (p value 0.002). Conclusions: Smoking and smokeless tobacco cessation programs need to be targeted at Tuberculosis patients.
Downloads
References
Global Tuberculosis report 2018, World health Organization. Available from: http://apps.who.int/iris/bitstream/handle/10665/274453/9789241565646-eng.Pdf?ua=1 [Accessed on 12/06/2019]
Fact sheet on tobacco March 2018 update: World Health Organization; 2017. Available from: http://www.who.int/ news-room/fact-sheets/detail/tobacco [Accessed on 12/06/2019]
India TB Report 2018. Revised National Tuberculosis Control Programme, Annual status Report, Ministry of Health and Family Welfare, India.
Global Adult Tobacco Survey-2, Fact Sheet India, 2016-17. Available from https://www.mohfw.gov.in/sites/default/ files/GATS-2%20FactSheet.pdf . [Accessed on 12/06/2019]
The end TB strategy. World health organization Geneva. 2015. Available from http://www.who.int/tb/End_TB_ brochure.pdf [Accessed on 12/06/2019]
Mukhya Mantri Kshay Rog Yojna, Himachal Pradesh. Available from http://himachalpr.gov.in/PressReleaseBy Year.aspx?Language=1&ID=13291&Type=2 [Accessed on 12/06/2019]
D’Arc Lyra Batista J, de Alencar Ximenes R, Rodrigues L. Smoking increases the risk of relapse after successful tuberculosis treatment. Int J Epidemiol 2008; 37: 841–851.
Leung CC, Li T, Lam TH, Yew WW, Law WS, Tam CM, Chan WM, Chan CK, Ho KS, Chang KC. Smoking and tuberculosis among the elderly in Hong Kong. Am J Respir Crit Care Med. 2004 Nov 1;170(9):1027-33. doi: 10.1164/rccm.200404-512OC. Epub 2004 Jul 28. PubMed PMID: 15282201.[PubMed].
Tachfouti N, Nejjari C, Benjelloun MC, Berraho M, Elfakir S, El Rhazi K, Slama K. Association between smoking status, other factors and tuberculosis treatment failure in Morocco. Int J Tuberc Lung Dis. 2011 Jun;15(6):838-43. doi: 10.5588/ijtld.10.0437. PubMed PMID: 21575308.[PubMed].
Goel S, Kathiresan J, Singh P, Singh RJ. Effect of a brief smoking cessation intervention on adult tobacco smokers with pulmonary tuberculosis: A cluster randomized controlled trial from North India. Indian J Public Health 2017;61: S47-53.
Global Adult Tobacco Survey Collaborative Group. Tobacco questions for surveys: a subset of key questions from the global adult tobacco survey. 2nd ed. Atlanta: Centres for Disease Control and Prevention; 2011.
Dinking levels defined. National Institute of alcohol abuse and alcoholism. Available from https://www.niaaa.nih.gov/ alcohol-health/overview-alcohol-consumption/ moderate-binge-drinking. [Accessed on 12/06/2019]
Reddy DS, Rao R, B. P. Ravi Kumar. Factors Influencing Treatment Outcome of New Sputum Smear Positive Tuberculosis Patients in Tuberculosis Unit Khammam. Int J Med Health Sci. 2013; 2(2): 195-204.
Sadana P, Singh T, Deepti SS. Socio-Demographic Factors affecting the Treatment Outcome in Patients of Tuberculosis. Ntl J of Community Med. 2015; 6(4):609-613.
WHO global report on trends in prevalence of tobacco smoking 2000–2025, second edition. Geneva: World Health Organization; 2018. Available from http://apps.who.int/ iris/bitstream/handle/10665/272694/9789241514170-eng.pdf?ua=1 [Accessed on 12/06/2019]
Gegia M, Magee MJ, Kempker RR, Kalandadze I, et al. Tobacco smoking and tuberculosis treatment outcomes: a prospective cohort study in Georgia. Bull World Health Organ. 2015; 93(6):390–99.
Veerakumar AM1, Sahu SK, Sarkar S, Kattimani S. Factors affecting treatment outcome among Pulmonary Tuberculosis patients under RNTCP in urban Pondicherry, India. Indian J Comm Health. 2016; 28, 1: 94-99
Gupta PC, Pednekar MS, Parkin DM, Sankaranarayanan R. Tobacco associated mortality in Mumbai (Bombay) India. Results of the Bombay Cohort Study. Int J Epidemiol. 2005 Dec;34(6):1395-402. doi: 10.1093/ije/dyi196. Epub 2005 Oct 25. PubMed PMID: 16249218.[PubMed].
Rehm J, Samokhvalov AV, Neuman MG, Room R, Parry C, Lönnroth K, Patra J, Poznyak V, Popova S. The association between alcohol use, alcohol use disorders and tuberculosis (TB). A systematic review. BMC Public Health. 2009 Dec 5;9:450. doi: 10.1186/1471-2458-9-450. Review. PubMed PMID: 19961618; PubMed Central PMCID: PMC2796667.[PubMed].
Jakubowiak WM, Bogorodskaya EM, Borisov SE, Danilova ID, Kourbatova EV. Risk factors associated with default among new pulmonary TB patients and social support in six Russian regions. Int J Tuberc Lung Dis. 2007 Jan;11(1):46-53. PubMed PMID: 17217129.[PubMed].
Singh PN, Natto Z, Yel D, Job J, Knutsen S. Betel quid use in relation to infectious disease outcomes in Cambodia. Int J Infect Dis. 2012 Apr;16(4):e262-7. doi: 10.1016/j.ijid.2011.12.006. Epub 2012 Jan 31. PubMed PMID: 22296863; PubMed Central PMCID: PMC3307941.[PubMed].
Haque MF, Harris M, Meghji S, Speight PM. An immunohistochemical study of oral submucous fibrosis. J Oral Pathol Med. 1997 Feb;26(2):75-82. PubMed PMID: 9049906.[PubMed].
Pillai MR, Balaram P, Kannan S, Sudha L, Nalinakumari KR, Hareendran NK, et al. Interferon activation of latent natural killer cells and alteration in kinetics of target cell lysis: clinical implications for oral precancerous lesions. Oral Surg Oral Med Oral Pathol. 1990; 70:458–461.
Yeager DS, Krosnick JA. The validity of self-reported nicotine product use in the 2001-2008 National Health and Nutrition Examination Survey. Med Care. 2010 Dec;48(12):1128-32. doi: 10.1097/MLR.0b013e3181ef9948. PubMed PMID: 20940652.[PubMed].
Bissell K, Fraser T, Chiang CY, Enarson DA. Smoking Cessation and Smokefree Environments for Tuberculosis Patients. Paris, France: International Union against Tuberculosis and Lung Disease; 2010
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2019 Indian Journal of Community Health
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
